Aurinia Pharmaceuticals AUPH Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's total equity?
- Aurinia Pharmaceuticals (AUPH) reported total equity of $567.63M in Q1 2026.
- How has Aurinia Pharmaceuticals's total equity changed year-over-year?
- Aurinia Pharmaceuticals's total equity increased by 62.1% year-over-year, from $350.19M to $567.63M.
- What is the long-term trend for Aurinia Pharmaceuticals's total equity?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total equity has grown at a 7.4% compound annual growth rate (CAGR), from $407.75M to $581.33M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.